- Home
- NBTX vs TSI Comparison
NBTX vs TSI Comparison
Compare NBTX & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- TSI
- Stock Information
- Founded
- NBTX 2003
- TSI 1987
- Country
- NBTX France
- TSI United States
- Employees
- NBTX N/A
- TSI N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- TSI Investment Managers
- Sector
- NBTX Health Care
- TSI Finance
- Exchange
- NBTX Nasdaq
- TSI Nasdaq
- Market Cap
- NBTX 211.9M
- TSI 234.6M
- IPO Year
- NBTX 2020
- TSI N/A
- Fundamental
- Price
- NBTX $4.57
- TSI $4.92
- Analyst Decision
- NBTX Strong Buy
- TSI
- Analyst Count
- NBTX 1
- TSI 0
- Target Price
- NBTX $8.00
- TSI N/A
- AVG Volume (30 Days)
- NBTX 7.1K
- TSI 106.8K
- Earning Date
- NBTX 04-02-2025
- TSI 01-01-0001
- Dividend Yield
- NBTX N/A
- TSI 7.46%
- EPS Growth
- NBTX N/A
- TSI N/A
- EPS
- NBTX N/A
- TSI N/A
- Revenue
- NBTX N/A
- TSI N/A
- Revenue This Year
- NBTX N/A
- TSI N/A
- Revenue Next Year
- NBTX $221.06
- TSI N/A
- P/E Ratio
- NBTX N/A
- TSI N/A
- Revenue Growth
- NBTX N/A
- TSI N/A
- 52 Week Low
- NBTX $2.76
- TSI $4.48
- 52 Week High
- NBTX $6.00
- TSI $4.87
- Technical
- Relative Strength Index (RSI)
- NBTX 52.43
- TSI 47.93
- Support Level
- NBTX $4.31
- TSI $4.87
- Resistance Level
- NBTX $5.00
- TSI $4.99
- Average True Range (ATR)
- NBTX 0.25
- TSI 0.05
- MACD
- NBTX -0.06
- TSI -0.00
- Stochastic Oscillator
- NBTX 24.44
- TSI 55.26
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About TSI TCW Strategic Income Fund Inc.
Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment and others.